Represented Visionary Venture Fund with its investment in Iantech, Inc., a US-based developer of a cataract treatment device. The Global Health Investment Fund also participated in this round. The company will use the funding to further R&D and commercial efforts for its miLOOP technology.
Visionary is a venture capital fund that invests in the future of ophthalmology, from startup to late-stage clinical trials. Its target investment range is $500K to $5M.
Newport Beach-based Bruce Feuchter and Jeff Estes advised Visionary.